GlobeNewswire PharmaOriginal article
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Neutral
AI Analysis
Summary
Syndax Pharmaceuticals granted inducement stock options to five new employees to purchase up to 59,250 shares of common stock under its 2023 Inducement Plan, with standard four-year vesting schedules.
Importance:1/10
Sentiment:
0.00
inducement grantsstock optionsemployee compensationNASDAQ compliance
Related Companies
Read the original article
Published by GlobeNewswire Pharma on August 5, 2026 8:01 PM